Both are Russian-approved. Both use intranasal delivery. Both affect BDNF. But they do different things — here's how to tell which one your research needs.
Research context only. All content is educational based on published research. Not medical advice.
Selank and Semax were both developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are approved for medical use in Russia. Both are used intranasally. Both affect BDNF. And yet they're different compounds with different primary effects that suit different research objectives.
| Selank | Semax | |
|---|---|---|
| Source | Tuftsin derivative | ACTH(4-7) derivative |
| Primary effect | Anxiolytic | Cognitive enhancement |
| BDNF effect | Upregulates | Stronger upregulation |
| Anxiety relief | Primary effect | Secondary effect |
| Cognitive enhancement | Secondary effect | Primary effect |
| Sedation risk | Very low | Very low |
| Stroke research | Limited | Approved for stroke in Russia |
| Russian approval | Yes (anxiety) | Yes (cognitive, stroke) |
| Typical route | Intranasal | Intranasal |
Selank is derived from tuftsin, an immune-modulating peptide. Its primary mechanism is GABA-A modulation (anxiolysis) and BDNF upregulation (cognitive support). The GABA component is what makes it a genuine anxiolytic — it directly reduces anxiety through the same receptor system as benzodiazepines, but without the sedation and dependence.
Semax is derived from ACTH(4-7) — a fragment of adrenocorticotropic hormone. It works primarily through BDNF and NGF upregulation, dopaminergic and serotonergic neurotransmission enhancement, and neuroprotective mechanisms. It doesn't have meaningful GABA activity — its mood-stabilizing effects come from monoamine modulation rather than GABAergic inhibition.
The stack rationale: Selank handles the anxiety side; Semax handles the cognitive performance side. Together they produce anxiolysis + enhanced mental performance — a combination that's difficult to achieve with single conventional compounds. This is the most common reason they're used together in research protocols.
| Goal | Better Choice | Why |
|---|---|---|
| Anxiety / stress management | Selank | Direct GABAergic anxiolytic mechanism |
| Cognitive performance / focus | Semax | Stronger BDNF + dopaminergic enhancement |
| Neuroprotection | Semax | Better neuroprotective data; stroke research |
| Anxiety + cognitive enhancement together | Stack both | Complementary mechanisms; the classic Russian nootropic stack |
| Sleep quality improvement | Selank | GABA modulation aids sleep initiation |
| BDNF maximization | Semax | Stronger BDNF upregulation in research data |
Choose based on your primary research objective. Anxiety as the primary concern: Selank. Cognitive enhancement as the primary concern: Semax. Both? Stack them — it's the most studied and most logical combination for combined anxiolytic + nootropic research.
Both have genuine regulatory histories in Russia, both have non-trivial evidence bases, and both have cleaner safety profiles than conventional psychiatric alternatives. The Western research community has been slower to study them, which creates a data asymmetry — but it doesn't negate the Russian clinical experience.
COA-verified vendor pricing with promo codes and reconstitution guide.
View Pricing → Dosage CalculatorCOA-verified vendor pricing with promo codes and reconstitution guide.
View Pricing → Dosage Calculator